Dechra Pharmaceuticals
LSE:DPH GB0009633180
Key Information
HQ:
United Kingdom
Market Cap:
$4.79bn
Primary Markets:
Europe & Russia, North America
Date
Description
Project Type
Key Topic
Content Type
May
2023
Dechra Pharmaceuticals PLC Assessment
Animal Pharmaceuticals Engagement
Antibiotics & Health